Related Experiment Video
Updated: Oct 27, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term
Philipp Kohler1, Salome N Seiffert2, Simone Kessler1
1Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
Extended-spectrum β-lactamase (ESBL)-producing Enterobacterales colonization is low in Swiss long-term care facilities, but clusters exist. Proton-pump inhibitor (PPI) use is a modifiable risk factor for ESBL carriage.
Area of Science:
- Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Extended-spectrum β-lactamase (ESBL)-producing Enterobacterales pose a significant threat in healthcare settings.
- Long-term care facilities (LTCFs) are vulnerable environments for the spread of antimicrobial resistance.
Purpose of the Study:
- To determine the prevalence and molecular epidemiology of ESBL-producing Enterobacterales in Swiss LTCFs.
- To identify intrainstitutional and regional clusters of resistant pathogens.
- To pinpoint factors associated with ESBL colonization in residents.
Main Methods:
- A cross-sectional point prevalence study was conducted in 16 Swiss LTCFs.
- Residents were screened for ESBL-producing Enterobacterales (ESBL-E), and whole-genome sequencing (WGS) was performed.
- Institution- and resident-level data were collected, and a generalized linear model was used for analysis.
Main Results:
- ESBL-E prevalence was 11.6% among 606 participating residents.
- Multilocus sequence type (ST) 131, particularly subclone H30R1, was the most common *Escherichia coli*.
- Independent risk factors for ESBL carriage included prior colonization, male gender, and proton-pump inhibitor (PPI) use.
Conclusions:
- While overall ESBL-E prevalence is low in Swiss LTCFs, localized clusters necessitate targeted infection control.
- Proton-pump inhibitor (PPI) use emerged as a modifiable risk factor, suggesting a need to restrict its use in LTCFs.
Related Concept Videos
Development of Antibiotic Resistance
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Gene Regulation in Microbial Communities: Quorum Sensing
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness
Acute Pyelonephritis II: Diagnostic Studies and Management

